TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $834,000 | +39.9% | 11,572 | +6.6% | 0.00% | 0.0% |
Q3 2020 | $596,000 | -17.5% | 10,857 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $722,000 | -23.4% | 10,857 | -29.6% | 0.00% | -50.0% |
Q1 2020 | $943,000 | -30.9% | 15,420 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $1,365,000 | +17.4% | 15,420 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $1,163,000 | -55.0% | 15,420 | -49.0% | 0.00% | -60.0% |
Q2 2019 | $2,585,000 | +0.3% | 30,261 | +26.9% | 0.01% | 0.0% |
Q1 2019 | $2,577,000 | +65.0% | 23,837 | +29.2% | 0.01% | +66.7% |
Q4 2018 | $1,562,000 | +407.1% | 18,453 | +574.2% | 0.00% | – |
Q3 2017 | $308,000 | -12.5% | 2,737 | -12.8% | 0.00% | -100.0% |
Q2 2017 | $352,000 | +33.3% | 3,140 | +38.8% | 0.00% | 0.0% |
Q1 2017 | $264,000 | -0.4% | 2,263 | -10.2% | 0.00% | 0.0% |
Q4 2016 | $265,000 | +6.0% | 2,519 | +11.5% | 0.00% | 0.0% |
Q3 2016 | $250,000 | -48.1% | 2,260 | -31.7% | 0.00% | 0.0% |
Q2 2016 | $482,000 | +72.1% | 3,311 | +69.3% | 0.00% | 0.0% |
Q1 2016 | $280,000 | -14.1% | 1,956 | -7.3% | 0.00% | 0.0% |
Q4 2015 | $326,000 | – | 2,110 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
FORT, L.P. | 9,672 | $730,000 | 0.14% |
CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |